- Home
- IMUX vs MNSB Comparison
IMUX vs MNSB Comparison
Compare IMUX & MNSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMUX
- MNSB
- Stock Information
- Founded
- IMUX 2016
- MNSB 2003
- Country
- IMUX United States
- MNSB United States
- Employees
- IMUX N/A
- MNSB N/A
- Industry
- IMUX Biotechnology: Pharmaceutical Preparations
- MNSB Major Banks
- Sector
- IMUX Health Care
- MNSB Finance
- Exchange
- IMUX Nasdaq
- MNSB Nasdaq
- Market Cap
- IMUX 107.3M
- MNSB 118.0M
- IPO Year
- IMUX N/A
- MNSB N/A
- Fundamental
- Price
- IMUX $0.69
- MNSB $18.72
- Analyst Decision
- IMUX Strong Buy
- MNSB
- Analyst Count
- IMUX 6
- MNSB 0
- Target Price
- IMUX $11.60
- MNSB N/A
- AVG Volume (30 Days)
- IMUX 1.4M
- MNSB 24.2K
- Earning Date
- IMUX 05-15-2025
- MNSB 04-21-2025
- Dividend Yield
- IMUX N/A
- MNSB 2.10%
- EPS Growth
- IMUX N/A
- MNSB N/A
- EPS
- IMUX N/A
- MNSB N/A
- Revenue
- IMUX N/A
- MNSB $59,896,000.00
- Revenue This Year
- IMUX N/A
- MNSB $17.95
- Revenue Next Year
- IMUX N/A
- MNSB $2.52
- P/E Ratio
- IMUX N/A
- MNSB N/A
- Revenue Growth
- IMUX N/A
- MNSB N/A
- 52 Week Low
- IMUX $0.56
- MNSB $15.00
- 52 Week High
- IMUX $2.11
- MNSB $20.88
- Technical
- Relative Strength Index (RSI)
- IMUX 27.13
- MNSB 54.14
- Support Level
- IMUX $0.56
- MNSB $18.68
- Resistance Level
- IMUX $0.95
- MNSB $19.90
- Average True Range (ATR)
- IMUX 0.07
- MNSB 0.55
- MACD
- IMUX -0.03
- MNSB -0.16
- Stochastic Oscillator
- IMUX 22.66
- MNSB 33.84
About IMUX Immunic Inc.
Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.
About MNSB MainStreet Bancshares Inc.
MainStreet Bancshares Inc is a bank holding company. It is focused on serving the borrowing, cash management and depository needs of small to medium-sized businesses, and professional practices and retail customers. The bank's products and services include business and consumer checking, premium interest-bearing checking, business account analysis, savings, certificates of deposit and other depository services, as well as a broad array of commercial, real estate and consumer loans.